JFL Life Sciences Limited (NSE:JFLLIFE)

Market Cap	341.50M -20.4%
Revenue (ttm)	1.31B +55.7%
Net Income	67.69M +126.3%
EPS	2.05 +162.5%
Shares Out	33.00M
PE Ratio	5.06
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,000
Open	9.90
Previous Close	9.90
Day's Range	9.90 - 10.35
52-Week Range	8.55 - 15.40
Beta	-0.29
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About JFL Life Sciences

JFL Life Sciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers beta lactam dry powder injections, beta lactam tablets and capsules in solid oral dosage form, oral rehydration solutions, and general tablets and capsules. It also exports its products to Africa, the Middle East, and CIS countries through merchant exporters. JFL Life Sciences Limited was incorporated in 2010 and is headquartered in Ahmedabad, India.

• Industry: Pharmaceutical Preparations
• Founded: 2010
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: JFLLIFE

Financial Performance

In fiscal year 2026, JFL Life Sciences's revenue was 1.31 billion, an increase of 60.15% compared to the previous year's 820.42 million. Earnings were 64.01 million, an increase of 53.96%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 28, 2026

Data Sources Report a data error